The association of varying treatment thresholds of mepolizumab on asthma exacerbations in adults-Reference-Cited by-同舟云学术

The association of varying treatment thresholds of mepolizumab on asthma exacerbations in adults

Published:2023-06-27 Issue:12 Volume:60 Page:2198-2206
ISSN:0277-0903
Container-title:Journal of Asthma
language:en
Short-container-title:Journal of Asthma

Author:

Davis Jaclyn¹,McMahon Pamela M.²,Simon Andrew²,Haffenreffer Katherine²,Jamal-Allial Aziza³,McMahill-Walraven Cheryl N.⁴,Kline Anne Marie⁴,Brown Jeffrey S.²,Van Dyke Melissa K.⁵,Jakes Rupert W.⁵,Wu Ann Chen¹²

Affiliation:

1. Boston Children’s Hospital, Boston, MA, USA

2. Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, USA

3. HealthCore, Inc, Watertown, MA, USA

4. CVS Health Clinical Trial Services, Blue Bell, PA, USA

5. Respiratory Epidemiology Therapy Area, GlaxoSmithKline, Collegeville, PA, USA

Publisher

Informa UK Limited

Subject

Pulmonary and Respiratory Medicine,Immunology and Allergy,Pediatrics, Perinatology and Child Health

Link

https://www.tandfonline.com/doi/pdf/10.1080/02770903.2023.2228900

Reference33 articles.

1. Centers for Disease Control. Most Recent National Asthma Data | CDC [Internet]; 2021. Available at: https://www.cdc.gov/asthma/most_recent_national_asthma_data.htm

2. Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention; 2021.

3. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma

4. Endotyping asthma: new insights into key pathogenic mechanisms in a complex, heterogeneous disease

5. Expert Panel Report 3 (EPR-3): guidelines for the diagnosis and management of asthma-summary report 2007;National Asthma Education and Prevention Program.;J Allergy Clin Immunol,2007